Although the emission spectra and excited-state lifetime of Ru(bpy) 3 2+ (bpy=2,2′-bipyridine), Ru(dmbpy) 3 2+ (dmbpy=4,4′- dimethyl-2,2′-bipyridine) and Ru(phen) 3 2+ (phen=1,10-phenanthroline) are little affected by the addition of the cationic surfactant cetyltrimethylammonium chloride (CTAC), an appreciable shift in λ max em , emission intensity and emission lifetime are observed for Ru(dtbpy) 3 2+ (dtbpy=4,4′-di-tert-butyl-2,2′-bipyri dine) and Ru(dpphen) 3 2+ (dpphen=4,7-diphenyl-1,10-phenanthroline). These results point out the importance of hydrophobic interactions over the coulombic repulsion thereby bringing the ruthenium(II) complexes close to the cationic micelles. The rate of luminescence quenching of five *Ru(NN) 3 2+ complexes, with alkyl-substituted phenolate ions in the presence of CTAC, follows different trends depending on the nature of the ligand in Ru(NN) 3 2+ as well as the quencher. The micellar inhibition is explained by considering ArO - being strongly associated with CTAC leaving Ru(NN) 3 2+ in the aqueous phase. The micellar catalysis at high [CTAC] with Ru(dtbpy) 3 2+ and Ru(dpphen) 3 2+ may be due to the operation of predominant hydrophobic interaction over the electrostatic repulsion.
No takes yet. Share an insight, caveat, or question.
Rajendran et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: